Clinical trial
Randomized Discontinuation Study of BAY 43-9006 in Patients With Advanced Refractory Cancer.
NCT00079612 is registered in ClinicalTrials.gov with Bayer as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Randomized Discontinuation Study of BAY 43-9006 in Patients With Advanced Refractory Cancer.
- Lead sponsor
- Bayer
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- September 30, 2002
- Completion date
- January 31, 2007
- Enrollment
- 501 (actual)
- Sites
- 7
Conditions
As the registry lists them; a condition with its own page is linked.